How to Help Your Patients Find Natesto in Stock: A Provider's Guide

For clinicians managing hypogonadal men on Natesto, access issues have become a recurring part of patient care. Natesto — the only FDA-approved intranasal testosterone gel — is not routinely stocked at every pharmacy, and insurance barriers add additional friction. This guide is designed to help providers take a proactive role in solving these access challenges so patients can stay on the treatment that works for them.

Why Your Patients Are Having Trouble Finding Natesto

The challenge is not a manufacturer shortage — Acerus Pharmaceuticals has not announced a supply disruption, and Natesto is not listed on the FDA Drug Shortage Database as of 2026. Instead, the difficulty is structural:

Natesto has no generic equivalent, meaning no competition to expand market penetration.

Each pump supplies only ~10 days of therapy, requiring patients to manage three dispensers per month.

Low relative prescription volume keeps pharmacy shelf priority low.

Schedule III classification adds inventory management burden for pharmacies.

Insurance coverage gaps — not covered by most Medicare; prior authorization required at many commercial plans.

Step 1 — Direct Patients to the Right Pharmacies

Advising patients to call their nearest CVS or Walgreens often leads to dead ends. Instead, direct them to:

Specialty pharmacies (e.g., CVS Specialty, Walgreens Specialty, Shields Health Solutions) — these locations serve TRT patients regularly and are more likely to stock Natesto.

Independent pharmacies — can special-order Natesto from wholesalers, often within 1–2 business days.

Urology or endocrinology practice-affiliated pharmacies — if your group has a relationship with a specialty pharmacy, establish Natesto as a stocked item.

Step 2 — Use medfinder to Streamline the Search

Rather than asking your staff or patients to spend time calling pharmacies, recommend medfinder — a paid service that calls pharmacies in a patient's area to find which ones have a specific medication in stock. The patient enters their medication, dosage, and ZIP code; medfinder does the calling; results come back via text. For patients who struggle with phone calls or live in rural areas, medfinder can be especially valuable.

Step 3 — Address the Cost Barrier Proactively

High out-of-pocket cost is one of the top reasons patients abandon Natesto. Ensure your prescribing workflow includes counseling on these programs:

Natesto Savings Card: For commercially insured patients. Co-pay as low as $0/month; up to $3,500 in annual savings. Offered through Acerus Pharmaceuticals (call 1-833-817-8688).

Natesto Cash Option Program: For uninsured or uninsured-not-covered patients. $140 per prescription (up to 30-day supply) for up to 12 refills.

GoodRx coupon: Brings retail price to approximately $165 at participating pharmacies for patients without applicable insurance.

Note that savings programs for Natesto require valid commercial insurance for the Savings Card benefit, and the Cash Option program has specific eligibility criteria. Patients should call 1-833-817-8688 to confirm their eligibility.

Step 4 — Streamline Prior Authorization Documentation

Prior authorization is a frequent barrier, especially for commercial plans that have Natesto at a high formulary tier. To increase PA approval rates, include in your documentation:

Two morning serum testosterone values below 300 ng/dL with associated symptoms

Specific clinical justification for intranasal route: fertility preservation concern, skin condition precluding topical use, occupational exposure risk to family members, prior adverse reaction to other formulations

Documentation of nasal anatomy clearance (no deviated septum, no chronic rhinitis, no recent nasal surgery)

If step therapy required: documentation of any prior trial of and inadequate response to alternative testosterone therapy

Step 5 — Prepare Patients with a Backup Plan

For patients who are highly motivated to stay on Natesto, counsel them to:

Begin searching for their refill a few days before running out, not the day of.

Establish a consistent relationship with a specialty pharmacy that agrees to maintain stock.

Have a backup prescription on file for an alternative formulation in case of a prolonged access gap.

When to Switch Formulations

If a patient cannot reliably access Natesto despite these measures, a formulation switch may be appropriate. All FDA-approved testosterone replacement therapies deliver the same active hormone. Generic testosterone topical gel and testosterone cypionate injections are widely stocked, significantly lower in cost, and broadly covered. Discuss the switch openly with the patient, including the fertility implications for younger patients.

For a complete clinical overview of the shortage situation, see our guide on the Natesto shortage and what providers need to know.